India looking at $11 bn market op in Covid vaccines

August 17, 2021 11:13

India's pharmaceutical sector is looking at an opportunity to the tune of USD 10 to 11 billion in the form of COVID-19 vaccine supply, in both domestic and export markets in the next three years, rating agency Care Ratings has said in a report.

However, the Indian vaccine makers are unlikely to get the premium pricing being enjoyed by US-based multinational companies which is anywhere between USD 15 and 25 per dose, their average realization could remain anywhere between USD 3.25 and USD 3.50 per dose, it said.

« Back to LIVE

TOP STORIES

Helicopter carrying Iranian President Raisi suffers 'hard landing'

The details of the incident remain unknown as of now, however, initial reports suggest that the accident involved the president's helicopter and foggy weather.

In Pictures - Sunrisers demolish Punjab Kings to go second

Images from the IPL match between Punjab Kings and Sunrisers Hyderabad, at the Rajiv Gandhi stadium, Hyderabad, on Sunday.

Luxury car mows down 2 in Pune; teen driver's father, bar to be booked

The 17-year-old car driver was detained after a case was registered against him. He was produced in a juvenile court which granted him bail, they said.

Verstappen steals the show at Imola

Max Verstappen held off a late charge by McLaren's Lando Norris to win the Emilia Romagna Grand Prix

Phase 5: Rae Bareli, Amethi go to polls on Monday

Besides Defence Minister Singh (Lucknow), Minister of Women and Child Development Irani (Amethi), those in the fray are Minister of State for Housing and Urban Affairs Kaushal Kishor (Mohanlalganj) and Minister of State of Consumer...